The investigation aims to demonstrate the first puncture success rate, as proxy of clinical benefit and clinical performance, of bioimpedance spectroscopy based spinal needle guidance method among pediatric hemato-oncology patients requiring lumbar punctures.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The First Puncture Success Rate
Timeframe: The assessment immediately following each lumbar puncture procedure
Rate of Serious Adverse Events
Timeframe: The assessment during four-week follow-up after each lumbar puncture procedure